Početna stranicaME • NASDAQ
add
23andMe Holding Co.
0,39 $
Poslije radnog vremena:(5,55 %)+0,022
0,41 $
Zatvoreno: 28. lip, 20:00:00 GMT -4 · USD · NASDAQ · Odricanje od odgovornosti
Preth. zaklj. cijena
0,42 $
Dnevni raspon
0,39 $ - 0,44 $
Godišnji raspon
0,35 $ - 2,03 $
Tržišna kapitalizacija
183,57 mil. USD
Prosječna količina
4,49 mil.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
NASDAQ
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | ožu 2024.info | Godišnja promjena |
---|---|---|
Prihod | 64,03 mil. | −30,69 % |
Operativni troškovi | 53,15 mil. | −51,42 % |
Neto dohodak | −208,83 mil. | −225,80 % |
Neto profitabilnost | −326,16 | −370,04 % |
Zarada po dionici | −0,43 | −206,96 % |
EBITDA | −22,06 mil. | 64,57 % |
Efektivna porezna stopa | −0,01 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | ožu 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 216,49 mil. | −44,04 % |
Ukupna imovina | 395,17 mil. | −58,08 % |
Ukupne obveze | 206,65 mil. | −9,63 % |
Ukupni kapital | 188,52 mil. | — |
Dionice u optjecaju | 490,26 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 1,11 | — |
Povrat imovine | −13,02 % | — |
Povrat kapitala | −18,11 % | — |
Tok novca
Neto promjena novca
(USD) | ožu 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | −208,83 mil. | −225,80 % |
Gotovina od poslovanja | −25,78 mil. | 42,65 % |
Gotovina iz ulaganja | −2,15 mil. | 34,73 % |
Gotovina iz financiranja | 2,00 mil. | −23,25 % |
Neto promjena novca | −25,93 mil. | 43,57 % |
Slobodan tok novca | 50,88 mil. | 282,19 % |
Više
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Glavni izvršni direktor
Osnovano
tra 2006
Web-lokacija
Zaposlenici
571